The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(4-(4,4-dimethylcyclohexyloxy)-5-fluoro-2-methoxybenzyl)pyrrolidine-2-carboxamide ID: ALA1091105
Cas Number: 1224048-09-2
PubChem CID: 46830177
Product Number: S669260, Order Now?
Max Phase: Preclinical
Molecular Formula: C21H31FN2O3
Molecular Weight: 378.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC2CCC(C)(C)CC2)c(F)cc1CNC(=O)[C@@H]1CCCN1
Standard InChI: InChI=1S/C21H31FN2O3/c1-21(2)8-6-15(7-9-21)27-19-12-18(26-3)14(11-16(19)22)13-24-20(25)17-5-4-10-23-17/h11-12,15,17,23H,4-10,13H2,1-3H3,(H,24,25)/t17-/m0/s1
Standard InChI Key: FGJOAGVKQWXJAD-KRWDZBQOSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
6.8902 -15.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8891 -15.8982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6039 -16.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3203 -15.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3175 -15.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6021 -14.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0304 -14.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7464 -15.0618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4593 -14.6466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1750 -15.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4562 -13.8216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1533 -15.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9301 -16.1586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4344 -15.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9692 -14.8243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1757 -14.6585 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.0355 -16.3091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0367 -17.1341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1743 -16.3101 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4601 -15.8970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4647 -15.0724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7547 -14.6594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -15.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0349 -15.8938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7494 -16.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8167 -14.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2333 -15.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 7 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 10 1 0
3 4 2 0
1 16 1 0
7 8 1 0
4 17 1 0
17 18 1 0
8 9 1 0
2 19 1 0
4 5 1 0
19 20 1 0
20 21 1 0
10 9 1 1
2 3 1 0
9 11 2 0
10 12 1 0
5 6 2 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
6 1 1 0
23 26 1 0
1 2 2 0
23 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.49Molecular Weight (Monoisotopic): 378.2319AlogP: 3.55#Rotatable Bonds: 6Polar Surface Area: 59.59Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.78CX Basic pKa: 9.80CX LogP: 3.26CX LogD: 0.91Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -0.09
References 1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB.. (2010) Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity., 20 (7): [PMID:20202843 ] [10.1016/j.bmcl.2010.01.107 ]